IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, giving promising developments across many clinical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, more dependable alternate for therapeutic use, specially in